Met Life Investment Management, LLC Harrow Health, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 17,882 shares of HROW stock, worth $604,948. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,882
Previous 17,882
-0.0%
Holding current value
$604,948
Previous $373,000
115.28%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$135 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$73.2 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$72.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$63.2 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$24.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $916M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...